Molecular genetics of Huntington's Disease: When size does matter

Journal of Cell and Molecular Biology

Volumn 6, Issue 1, 2007, Pages 1-8

  Ersoy, Nagehan ^a  

^a HALIC UNIVERSITY   (Turkey)

Author keywords

CAG repeats; Huntington's disease; Neurodegeneration; Polyglutamine

Indexed keywords

4 AMINOBUTYRIC ACID; ADENINE; CYTOSINE; GUANINE; HUNTINGTIN; POLYGLUTAMINE;

AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR DISORDER; CELL LOSS; CHROMOSOMAL INSTABILITY; CHROMOSOME 4P; CLINICAL FEATURE; COGNITIVE DEFECT; CORPUS STRIATUM; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EXON; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; GENE LOCATION; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; MOLECULAR GENETICS; MOTOR DYSFUNCTION; MUTATIONAL ANALYSIS; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PENETRANCE; POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SOUTHERN BLOTTING; SYMPTOM;

EID: 44949123944     PISSN: 13033546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Andrew SE, Goldberg YP, Theilmann J, Zeisler J and Hayden MR. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive power. Hum Mol Genet. 3: 65-67, 1994.
2. Andrew S, Goldberg P, Kremer B, Telenius H, Theilmann J, Adam SH, Staff E, Squiteiri F, Lin B, Kalchman M, Graham RK and Hayden MR. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics. 4: 398-403. 1993.
3. Barnes GT, Duyao MP, Ambrose CM, Mcneil S, Persichetti F, Srinidhi J, Gusella JF and Macdonald ME. Mouse Huntington's disease gene homolog (Hdh). Somat Cell Molec Gen. 20: 87-97, 1994.
4. Bates GP, Mangiarini L, Wanker EE and Davies SW. Polyglutamine expansion and Huntington's disease. Biochem Soc Trans. 26: 3:471-475, 1998.
5. Bates G, Harper P, Jones L. Huntington's disease. 3rd edition, London, Oxford Publ. 2002.
6. Baxendale S, Abdulla S, Elgar G, Buck D, Berks M, Micklem G, Durbin R, Bates G, Brenner S, Beck S and Lehrach H. Comparative sequence analysis of the human and pufferfish Huntington's disease genes. Nature Genetics. 10: 67-76, 1995.
7. Bier ED and Iversen LL. Huntington's Chorea: Postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase, and dopamine in basal ganglia. Brain. 97: 457-472, 1997.
8. Brinkman RR, Mezei MM, Theilmann J, Almqviq E and Hayden MR. The likelihood of being affected with Huntington disease by a particular age for a specific CAG size. American Journal of Human Genetics. 60: 1202-1210, 1997.
9. Craufurd D. Huntington's disease. Prenatal Diagnosis. 16: 1237-1245, 1996.
10. Craufurd D. Huntington's disease. Clinical Genetics. 1: 29-31, 1994.
11. Cummings CJ and Zoghbi HY. Fourteen and counting: unraveling trinucleotide repeat diseases. Hum Mol Genet. 12, 9: 909-16, 2000.
12. Davies S, Turmaine M, Cozens. BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L and Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90: 537-548, 1997.
13. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JPand Aronin N. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277: 1990-1993, 1997.
14. Djousse L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, Gomez-Tortosa E, Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME and Myers RE Interaction of normal and expanded CAG repeat sizes'influences age at onset of Huntington disease. Am J Med Genet. A. 15 (119): 279-82, 2003.
15. Farrer LA. Suicide and attempted suicide in Huntington's disease: implications for preclinical testing of persons at risk. Am J Med Genet. 24: 305-311, 1986.
16. Farrer LA, Cupples LA, Kiely DK, Conneally PM and Myers RH. Inverse relationship between age at onset of Huntington's disease and paternal age suggests involvement of genetic imprinting. Am J Med Genet. 50: 528-535, 1992.
17. Goldberg YP, Kremer B, Andrew SE, Heilmann J, Graham RK, Squiteiri F, Telenius H, Adam S, Sajaoo A, Starr E, Heiberg A, Wolff G and Hayden MR. Molecular analysis of new mutations for Huntington's disease, intermediate alleles and sex of origin effects. Nature Genetics. 5: 174-179, 1993.
18. Graveland GA., Williams RS and DiFiglia M. Medium spiny projection neurons, the predominant neurostriatal cell type, are particularly vulnerable in Huntington's disease. Science. 227; 770-773, 1985.
19. Graybi AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends in Neurosciences. 143: 244-254, 1990.
20. Gusella JF and MacDonald ME. Huntington's disease. Cell Biology. 6: 21-28, 1995.
21. Hall JG. and\Te-Juatco L. Association between age of onset and parental inheritance in Huntington's chorea. Am J Med Gen. 16: 289-290, 1983.
22. Hannan A.J. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease. Acta Biochim Pol. 51 (2): 415-30, 2004.
23. Harper PS. Huntington's disease. 2nd edition, Londra, WB Saunders Publ., 1996.
24. Harper PS. The epidemiology of Huntington's disease. Human Genetics. 89: 365-376, 1992.
25. Huntington G. "On chorea". Medical and Surgical Repoter.26: 320-321, 1972.
26. Huntington's disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 26, 72 (6): 971-983, 1993.
27. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology. 44(8):1533-1556, 1994.
28. James CM, Houlihan GD, Snell RG, Cheadle JPand Harper PS. Late Onset Huntington's disease. A clinical and genetic study. Age and Aging. 23: 445-448, 1994.
29. Jennings C.How Trinucleotide repeats may function?. Nature. 378: 127, 1995.
30. Karlovich CA, John RM, Ramirez L,. Stainier DY and Myers RM. Characterisation of the Huntington's disease (HD) gene hornologue in the zebrafish Danio Rerio. Gene. 217(1-2): 117-125, 1998.
31. Li Z, Karlovich CA, Fish MP, Scott MP and Myers RM. A putative drosophila homolog of the Huntington's disease gene. Hum Mol Genet. 8(9): 1807-15, 1999.
32. Lin B, Nasir J, Kalchman MA, McDonald H, Zeisler J, Goldberg YPand Hayden MR. Structural analysis of the 5′region of mouse and human Huntington disease genes reveals conservation of putative promoter region and trinucleotide polymorphisms. Genomics. 25: 707-715, 1995.
33. Macdonald ME, Novelletto A, Lin C, Tagle D, Barnes G, Taylor S, Allitto B, Altherr M, Myers R, Lehrach H, Collins FS, Wasmuth JJ, Frontali M, and Gusella JF. The Huntington's disease candidate region exhibits many different haplotypes. Nature Genetics. 1: 99-103, 1992.
34. Matsuyama N, Hadano S, Onoe K, Hitoshi O, Showguchi-Miyata J, Gondo Y and Ikeda J. Identification and characterisation of the miniature pig Huntington's disease gene homolog: evidence for conservation and polyrnorphism in the CAG triplet repeat. Genomics. 69: 72-85, 2000.
35. McGlennan RC, Allinson PS, Matthias-Hagen VL, Parker TL, Lovell MA, Kelley TA. Evidence of an unstable paternal 27 CAG repeat allele in the Huntingtin gene giving rise to clinically overt Huntington disease in a patient with the genotype (17/38). Am J Hum Genet Suppl. 57: A246, 1995.
36. Monte SM, Vonsattel JP and Richardson EP. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter and neostriatum in Huntington's disease. Journal of Neuropathology and Experimental Neurology. 47: 516-525, 1988.
37. Richards RI and Sutherland GR. Simple repeat DNA is not replicated simply. Nature Genetics. 6: 114-116, 1994.
38. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Cormarty M, Crauford D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC and Hayden MR. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet.59: 16-22, 1994.
39. Rubinszteih DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassinian J J, Chotai K, Connarty M, Craufurd D, Curtis A, Curtis D, Davidson MJ, Differ AM, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz,ML,. Graham CA, Harper PS, Hedreen JC, Morrison P, Trottier Y, Novelletto A, Simpson SA, Theilmann J, Whittaker JL, Folstein SE, Ross CA and Hayden MR. Phenotypic Characterization of Individuals with 30-40 CAG Repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal Elderly Individuals with 36-39 Repeats. Am J Hum Genet. 59:16-22, 1996.
40. Schmitt I, Bachner D, Megow D, Henklein P, Hameister H, Epplen Mand Riess O.Expression of the Huntington disease One in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development. Hum Mol Genet. 4: 1173-1182, 1995.
41. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relatioship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet. 4(4): 393-397, 1993.
42. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, and Ross CA. Correlation between the onset age of the Huntington's disease and length of the trinucleotide Repeat in IT-15. Human Molecular Genetics. 2: 1547-1549, 1993.
43. Strong, TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, and Albib RL. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genetics. 5: 259-265, 1993.
44. n changes in Huntington disease. Hum Mol Genet. 4: 189-195. 1995.
45. Telenius HM, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, Adam S, Greenberg C, Ives EJ, Clarke LA and Hayden MR. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet. 6: 409-414, 1994.
46. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet. 62: 1243-1247. 1998.
47. Wells RD and Warren ST. Genetic instabilities and hereditary neurological disorders, Academic Press, California. 1998.